Consequently, AR exhibits a notable correlation with tumor aggressiveness and the prognosis of endometrial cancer, positioning it as a promising candidate for understanding tumor progression (Duska, Zadeh & Mills, 2018; Hussain et al., 2018). This evidence concerns the gene AR and endometrial cancer.